(February 26, 2020, 2:57 PM EST) -- SAN FRANCISCO — The federal judge in California overseeing the Juul Labs Inc. multidistrict litigation informed the parties during a Feb. 14 case management conference that he is not inclined to stay the case pending Food and Drug Administration action but invited them to submit briefs on preemption and jurisdiction issues “as soon as practicable” and stayed pending motions to remand (In Re: Juul Labs, Inc., Marketing, Sales Practices, And Products Liability Litigation, No. 19-2913, N.D. Calif.)....